9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Phigenix Fights $2.2M Atty Fee Bid In Cancer Drug IP Row

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Phigenix Fights $2.2M Atty Fee Bid In Cancer Drug IP Row

Phigenix Fights $2.2M Atty Fee Bid In Cancer Drug IP Row

Law360 (November 27, 2018, 7:58 PM EST) — Phigenix Inc. is fighting Genentech Inc.’s request for more than $2.2 million in attorneys’ fees after beating a patent infringement suit in California federal court over the breast cancer drug Kadcyla….

Call Now ButtonCall For Free Consultation